Skip to main content
. 2023 Jul 19;30:39–55. doi: 10.1016/j.omto.2023.07.006

Figure 6.

Figure 6

Temporal scRNA-seq gene expression signatures in medulloblastomas

(A) Heatmap showing differentially expressed genes in C134-treated day 6 medulloblastomas compared with C134-treated day 2, with an average log2 fold change of greater than 1.5 or less than −1.5. Top GO biological processes for greater than 1 average Log2 FC upregulated (B) and less than –1 average Log2 fold change downregulated (C) differentially expressed genes on day 6 vs. day 2 C134-treated medulloblastomas.